摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(chloromethyl)-6-methoxynaphthalene | 861094-04-4

中文名称
——
中文别名
——
英文名称
1-(chloromethyl)-6-methoxynaphthalene
英文别名
1-Chloromethyl-6-methoxy-naphthalene
1-(chloromethyl)-6-methoxynaphthalene化学式
CAS
861094-04-4
化学式
C12H11ClO
mdl
——
分子量
206.672
InChiKey
LOXGELNNCVYJGJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(chloromethyl)-6-methoxynaphthalene硫酸 、 xylene 作用下, 生成 3-ethylidene-7-methoxy-2-methyl-2,3-dihydro-1H-cyclopenta[a]naphthalene-2-carboxylic acid methyl ester
    参考文献:
    名称:
    Acupuncture and Clinical Hypnosis for Facial and Head and Neck Pain: A Single Crossover Comparison
    摘要:
    Despite their long histories, acupuncture and hypnosis have only recently been acknowledged as valuable by the medical establishment in the U.S. Few studies have used rigorous prospective measurement to evaluate the individual or relative merits of hypnosis and acupuncture in specific clinical settings.In this study, 25 patients with various head and neck pain were studied. Each had an initial assessment of their pain, as well as of their attitudes and expectations. All patients received acupuncture, followed by a reassessment of their pain. After a washout period they received another assessment of pain before and after hypnosis therapy. Preferences for therapy were sought following the hypnotic intervention.Both acupuncture and hypnosis were effective at relieving pain under these conditions. The average relief in pain reported was 4.2 units on a ten point scale, with hypnosis reducing pain by a mean of 4.8 units, compared to 3.7 for acupuncture (p = 0.26). Patient characteristics appeared to impact the effectiveness of treatment: patients with acute pain benefited most from acupuncture treatment, whereas patients with psychogenic pain were more likely to benefit from hypnosis. Patients with chronic pain had more variation in their results. Patients who received healing suggestions from a tape during a hypnotic trance benefited more than those who received no such suggestion, and acupuncture patients who were needle phobic benefited less than those who were not fearful of needles.This study demonstrates the benefits of well designed studies of the effectiveness of these alternative modalities. More work is needed to help practitioners identify which patients are most likely to benefit from these complementary therapies.
    DOI:
    10.1080/00029157.2001.10403469
  • 作为产物:
    描述:
    6-羟基-1-萘甲酸 在 lithium aluminium tetrahydride 、 氯化亚砜potassium carbonate 作用下, 以 四氢呋喃二氯甲烷丙酮 为溶剂, 反应 3.0h, 生成 1-(chloromethyl)-6-methoxynaphthalene
    参考文献:
    名称:
    使用格氏试剂的 Pd 催化烯丙基脱芳构化
    摘要:
    通过使用格氏试剂,钯催化的萘基卤化物的烯丙基化脱芳构化被证明是可行的。亲核试剂的高反应活性允许快速反应和低催化剂负载,而大量成功取代的化合物说明了广泛的范围。五元杂芳族化合物也被证明在类似条件下具有反应性。
    DOI:
    10.1039/d1cc05609c
点击查看最新优质反应信息

文献信息

  • Pd-catalyzed allylative dearomatisation using Grignard reagents
    作者:Cosimo Boldrini、Syuzanna R. Harutyunyan
    DOI:10.1039/d1cc05609c
    日期:——
    naphthyl halides is shown to be feasible by employing Grignard reagents. The high reactivity of the nucleophile allows for fast reactions and low catalyst loading, while a plethora of successfully substituted compounds illustrate the broad scope. Five membered heteroaromatic compounds are also demonstrated to be reactive under similar conditions.
    通过使用格氏试剂,钯催化的萘基卤化物的烯丙基化脱芳构化被证明是可行的。亲核试剂的高反应活性允许快速反应和低催化剂负载,而大量成功取代的化合物说明了广泛的范围。五元杂芳族化合物也被证明在类似条件下具有反应性。
  • Synthesis and fluoride-induced chemiluminescent decomposition of bicyclic dioxetanes substituted with a 2-hydroxynaphthyl group
    作者:Naoyuki Hoshiya、Natsuki Fukuda、Hidetoshi Maeda、Nobuko Watanabe、Masakatsu Matsumoto
    DOI:10.1016/j.tet.2006.03.082
    日期:2006.6
    efficiency, and that dioxetane 1aA exhibited chemiluminescence with the highest efficiency among those for the oxynaphthyl-substituted dioxetanes hitherto known. The significant change in chemiluminescent efficiency depending on the substitution pattern was clarified to be attributed to the marked change in singlet-chemiexcitation efficiency for charge-transfer-induced chemiluminescence (CTICL) of 1aA–1eA
    合成了5个带有2-羟基萘基的双环二氧杂环丁烷1aA - 1eA,并使用四丁基氟化铵(TBAF)作为DMSO中的碱检查了它们的化学发光分解。发现这些二氧杂环丁烷完全保持了作为萘环上的引发剂的羟基的取代模式与其化学发光效率之间的'奇/偶'关系,并且二氧环乙烷1aA在迄今为止已知的氧萘基取代的二氧杂环丁烷中,化学发光显示出最高的化学发光效率。化学发光效率的显着变化取决于取代模式,已明确归因于1aA – 1eA电荷转移诱导的化学发光(CTICL)的单重态化学激发效率的显着变化。关于CTICL分解的速率,观察到1aA – 1dA的“奇/偶”关系。
  • Crucial Dependence of Chemiluminescence Efficiency on the<i>Syn</i>/<i>Anti</i>Conformation for Intramolecular Charge-Transfer-Induced Decomposition of Bicyclic Dioxetanes Bearing an Oxidoaryl Group
    作者:Masakatsu Matsumoto、Haruna Suzuki、Nobuko Watanabe、Hisako K. Ijuin、Jiro Tanaka、Chizuko Tanaka
    DOI:10.1021/jo2006945
    日期:2011.6.17
    Thermally stable rotamers of bicyclic dioxetanes bearing 6-hydroxynaphthalen-1-yl (anti-5a and syn-5a), 3-hydroxynaphthalen-1-yl (anti-5b and syn-5b), and 5-hydroxy-2-methylphenyl groups (anti-5c and syn-5c) were synthesized. These dioxetanes underwent TBAF (tetrabutylammonium fluoride)-induced decomposition accompanied by the emission of light in DMSO and in acetonitrile at 25 °C. For all three pairs
    (双环二恶丁环轴承6-羟基萘-1-基的热稳定旋转异构体的抗-图5a和SYN -图5a),3-羟基萘-1-基(抗- 5B和SYN -图5b),和5-羟基-2-甲基苯基(抗- 5C和SYN -图5c)的合成。这些二氧杂环丁烷经历了TBAF(四丁基氟化铵)诱导的分解,并伴随着DMSO和乙腈在25°C下的发光。对于三对旋转异构体,化学发光效率Φ CL为抗- 5明显高于8-19倍,对于顺式- 5,和CTID(电荷转移诱导的分解)的用于速率抗- 5比更快顺- 5。旋转异构体在5a和5c上的化学发光光谱是不同的。这种差异在旋转异构体之间化学发光光谱可以推测是由于在的结构中的差从头酮酰亚胺抗- 14和SYN - 14处于激发态,其继承相应中介阴离子二恶丁环的结构的抗- 13和SYN - 13。从化学方法研究了氧化苯基取代的二氧杂环丁烷的CTID激发机理,讨论了anti - 5和syn - 5之间化学发光效率的重要区别。
  • Organic Compounds and Their Uses
    申请人:Brandl Trixi
    公开号:US20080045530A1
    公开(公告)日:2008-02-21
    The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
    本申请描述了有机化合物,可用于治疗、预防和/或改善人类疾病。
  • HCV inhibitors comprising beta amino acids and their uses
    申请人:Novartis AG
    公开号:EP2272858A2
    公开(公告)日:2011-01-12
    The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
    本申请介绍了可用于治疗、预防和/或改善人类疾病的有机化合物。
查看更多